Cancer Letters
Volume 228, Issue 1 , Pages 13-20 , 18 October 2005

Application of microarray-based technology to neuroblastoma

  • Paola Scaruffi

      Affiliations

    • Unit of Translational Paediatric Oncology, National Institute for Cancer Research (IST), Genoa, Italy
    • Italian Neuroblastoma Foundation, Advanced Biotechnology Center, Genoa, Italy
    • ,
  • Alexander Valent

      Affiliations

    • Genomique Cellulaire des Cancers, CNRS UMR 8125, Institut Gustave Roussy, Villejuif Cedex, France
    • ,
  • Alexander Schramm

      Affiliations

    • Division of Hematology/Oncology, University Children's Hospital, Essen, Germany
    • ,
  • Kathy Astrahantseff

      Affiliations

    • Division of Hematology/Oncology, University Children's Hospital, Essen, Germany
    • ,
  • Angelika Eggert

      Affiliations

    • Division of Hematology/Oncology, University Children's Hospital, Essen, Germany
    • ,
  • Gian Paolo Tonini

      Affiliations

    • Unit of Translational Paediatric Oncology, National Institute for Cancer Research (IST), Genoa, Italy
    • Corresponding Author InformationCorresponding author. Address: Unit of Translational Paediatric Oncology, National Institute for Cancer Research (IST), L.go R. Benzi, 10, 16132 Genoa, Italy. Tel.: +39 010 57 37 487; fax: +39 010 57 37 463.

Received 20 December 2004 ,Accepted 12 January 2005.

References 

  1. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270:467–470
  2. Shalon D, Smith SJ, Brown PO. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 1996;6:639–645
  3. Fodor SP, Read JL, Pirrung MC, Stryer L, Tsai Lu A, Solas D. Light-directed, spatially addressable parallel chemical synthesis. Science. 1991;251:767–773
  4. Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW. Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol. 1998;16:301–306
  5. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531–537
  6. Takita J, Ishii M, Tsutsumi S, Tanaka Y, Kato K, Toyoda Y, et al. Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma. Genes Chromosomes Cancer. 2004;40:120–132
  7. Hiyama E, Hiyama K, Yamaoka H, Sueda T, Reynolds CP, Yokoyama T. Expression profiling of favorable and unfavorable neuroblastomas. Pediatr. Surg. Int. 2004;20:33–38
  8. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med. 2001;7:673–679
  9. Berwanger B, Hartmann O, Bergmann E, Bernard S, Nielsen D, Krause M, et al. Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell. 2002;2:377–386
  10. Alaminos M, Mora J, Cheung NK, Smith A, Qin J, Chen L, et al. Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res. 2003;63:4538–4546
  11. Hiyama E, Hiyama K, Nishiyama M, Reynolds CP, Shay JW, Yokoyama T. Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity. J. Pediatr. Surg. 2003;38:1730–1734
  12. Janoueix-Lerosey I, Novikov E, Monteiro M, Gruel N, Schleiermacher G, Loriod B, et al. Gene expression profiling of 1p35–36 genes in neuroblastoma. Oncogene. 2004;23:5912–5922
  13. McArdle L, McDermott M, Purcell R, Grehan D, O'Meara A, Breatnach F, et al. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q. Carcinogenesis. 2004;25:1599–1609
  14. Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, et al. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics. 2004;20:70
  15. Krasnoselsky AL, Whiteford CC, Wei JS, Bilke S, Westermann F, Chen QR, et al. Altered expression of cell cycle genes distinguishes aggressive neuroblastoma. Oncogene. 2004;(Epub ahead of print)
  16. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. 2003;3:203–216
  17. Wei JS, Greer BT, Westermann F, Steinberg SM, Son CG, Chen QR, et al. Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res. 2004;64:6883–6891
  18. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer. 1999;86:349–363
  19. Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawara A, Goto S, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer. 2001;92:2451–2461
  20. Sidell N, Sarafian T, Kelly M, Tsuchida T, Haussler M. Retinoic acid induced differentiation of human neuroblastoma: a cell variant system showing two distinct responses. Exp. Cell Biol. 1986;54:287–300
  21. Tsokos M, Scarpa S, Ross RA, Triche TJ. Differentiation of human neuroblastoma recapitulates neural crest development: study of morphology, neurotransmitter enzymes, and extracellular matrix proteins. Am. J. Pathol. 1987;128:484–496
  22. Mora J, Cheung NK, Juan G, Illei P, Cheung I, Akram M, et al. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res. 2001;61:6892–6898
  23. Ambros IM, Zellner A, Roald B, Amann G, Ladenstein R, Printz D, et al. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma, N. Engl. J. Med. 1996;334:1505–1511
  24. Fend F, Raffeld M. Laser capture microdissection in pathology. J. Clin. Pathol. 2000;53:666–672
  25. Curran S, McKay JA, McLeod HL, Murray GI. Laser capture microscopy. Mol. Pathol. 2000;53:64–68
  26. Eberwine J, Spencer C, Miyashiro K, Mackler S, Finnell R. Complementary DNA synthesis in situ: methods and applications. Methods Enzymol. 1992;216:80–100
  27. De Preter K, Vandesompele J, Heimann P, Kockx MM, Van Gele M, Hoebeeck J, et al. Application of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells. Cancer Lett. 2003;197:53–61
  28. Yuza Y, Agawa M, Matsuzaki M, Yamada H, Urashima M. Gene and protein expression profiling during differentiation of neuroblastoma cells triggered by 13-cis retinoic acid. J. Pediatr. Hematol. Oncol. 2003;25:715–720
  29. Schulte JH, Schramm A, Pressel T, Klein-Hitpass L, Kremens B, Eils J, et al. Microarray-analysis: a new approach to study the molecular mechanisms of thermo-chemotherapy. Klin Padiatr. 2003;215:298–302
  30. J.H. Schulte, A. Schramm, L. Klein-Hitpass, M. Klenk, H. Wessels, B.P. Hauffa, et al., Microarray Analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA and TrkB expressing neuroblastomas, Oncogene, in press.
  31. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818–821
  32. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 1998;20:207–211
  33. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy I, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 2001;29:263–264
  34. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmuller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl Acad. Sci. USA. 1999;96:4494–4499
  35. Veltman JA, Schoenmakers EF, Eussen BH, Janssen I, Merkx G, van Cleef B, et al. High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization. Am. J. Hum. Genet. 2002;70:1269–1276
  36. Hodgson G, Hager JH, Volik S, Hariono S, Wernick M, Moore D, et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet. 2001;29:459–464
  37. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics. 1992;13:718–725
  38. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer. 2003;36:361–374
  39. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 1999;23:41–46
  40. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer. 1997;20:399–407
  41. Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, et al. Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc. Natl Acad. Sci. USA. 2003;100:2532–2537
  42. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 2002;62:6240–6245
  43. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl Acad. Sci. USA. 2002;99:12963–12968
  44. Clark J, Edwards S, Feber A, Flohr P, John M, Giddings I, et al. Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene. 2003;22:1247–1252
  45. Heiskanen MA, Bittner ML, Chen Y, Khan J, Adler KE, Trent JM, et al. Detection of gene amplification by genomic hybridization to cDNA microarrays. Cancer Res. 2000;60:799–802
  46. Beheshti B, Braude I, Marrano P, Thorner P, Zielenska M, Squire JA. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia. 2003;5:53–62
  47. Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, et al. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics. 2004;5:70
  48. Scaruffi P, Parodi S, Mazzocco K, Defferrari R, Fontana V, Bonassi S, et al. Detection of MYCN Amplification and Chromosome 1p36 Loss in Neuroblastoma by cDNA Microarray Comparative Genomic Hybridization. Mol. Diagn. 2004;8:93–100
  49. Guillaud-Bataille M, Valent A, Soularue P, Perot C, Inda MM, Receveur A, et al. Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGH. Nucleic. Acids Res. 2004;32:e112

PII: S0304-3835(05)00357-5

doi: 10.1016/j.canlet.2005.01.052

Cancer Letters
Volume 228, Issue 1 , Pages 13-20 , 18 October 2005

Article Tools